IPP Bureau
XenoTherapeutics to acquire Repare Therapeutics
By IPP Bureau - November 17, 2025
Lupin launches long-acting Risperidone in US
By IPP Bureau - November 17, 2025
This marks Lupin’s first commercial product leveraging PrecisionSphere, a proprietary long-acting injectable (LAI) technology
CIAN Agro to market Andhra Pradesh Medtech Zone’s medical device
By IPP Bureau - November 17, 2025
SPARC announces consolidation of R&D laboratories and facilities
By IPP Bureau - November 17, 2025
This strategic initiative aims to accelerate proof-of-concept of pipeline assets by streamlining R&D operations
Remedium Lifecare posts consolidated Q2 FY26 net profit higher at Rs. 8.62 Cr
By IPP Bureau - November 17, 2025
Consolidated revenue from operations stood at Rs. 111.05 crore
Samson Clinical completes patient recruitment for clinical trial of male-pattern baldness drug
By IPP Bureau - November 17, 2025
AGA affects up to 80 per cent of men across their lifetime and remains one of the most common and most psychologically challenging forms of hair loss
AstraZeneca and Sun Pharma partner to expand hyperkalemia treatment in India
By IPP Bureau - November 17, 2025
Both companies will promote, market and distribute Sodium Zirconium Cyclosilicate in India under different brand names
Briefs: Zydus, Divi's Laboratories and Relonchem
By IPP Bureau - November 17, 2025
FDA closes inspection at Zydus' oncology injectable manufacturing facility in SEZ1, Ahmedabad with 2 observations
WHO issues first global guidelines for managing diabetes in pregnancy
By IPP Bureau - November 17, 2025
Uncontrolled diabetes in pregnancy dramatically increases the risk of pre-eclampsia, stillbirth, birth injuries, and long-term cardiometabolic diseases
EMA recommends authorization of Teizeild to delay Type 1 diabetes onset
By IPP Bureau - November 17, 2025
This is the first drug to receive a recommendation for this preventative indication in the European Union
FDA concludes Lupin’s Nagpur Unit-1 facility inspection with zero observations
By IPP Bureau - November 16, 2025
Glenmark posts 72.2% jump in Q2 FY net profit at Rs. 610.4 Cr YoY
By IPP Bureau - November 16, 2025
EBITDA was Rs. 2,359.6 crore in the quarter ended September 30, 2025
Kilitch Drugs H! FY26 PAT up 18% YoY to Rs. 10.30 Cr
By IPP Bureau - November 16, 2025
Total income for the period stood at Rs. 7101.28 crore
Medico Remedies gets GMP compliance certificate from SMDC, Ukraine
By IPP Bureau - November 16, 2025
SMDC is a participating authority under Pharmaceutical Inspection Cooperation Scheme (PIC/S)
Amcor launches ultra-light Shadow roll-on for next-gen beauty branding
By IPP Bureau - November 16, 2025
The new shadow roll-on delivers strong on-shelf presence with its modern rounded-base design
